comparemela.com

Latest Breaking News On - Yatin suneja - Page 7 : comparemela.com

Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference

NEW YORK, Sept. 9, 2022 /PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the develo.

New-york
United-states
Yatin-suneja
Raj-mehra
Mike-moyer
Anthony-marciano
Prnewswire-seelos-therapeutics-inc
Lifesci-advisors
Seelos-therapeutics-inc
Nasdaq
Guggenheim-nantucket-therapeutics-conference
Senior-biotechnology-analyst-yatin-suneja

Axsome's depression drug enters competitive market after US approval

the Food and Drug Administration approved Axsome Therapeutics anti-depression drug Auvelity which reduces symptions as early as one week.

United-states
Americans
Yatin-suneja
Axsome-therapeutics-inc-on
Johnson
Axsome-therapeutics-inc

Axsome's depression drug enters competitive market after U.S. approval

Axsome's depression drug enters competitive market after U.S. approval
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Americans
Yatin-suneja
Amruta-khandekar
Axsome-therapeutics-inc-on
Johnson
Reuters
Axsome-therapeutics-inc
Anild-silva

Axsome Therapeutics (AXSM) Q2 2022 Earnings Call Transcript

AXSM earnings call for the period ending June 30, 2022.

United-states
Chris-howerton-jefferies
Herriot-tabuteau
Matt-kaplan
Jason-gerberry
Graig-suvannavejh
Charles-duncan
Nick-pizzie
Ram-selvaraju
Charles-duncan-cantor-fitzgerald
Joseph-thome-cowen
Yatin-suneja-guggenheim

Neurocrine Biosciences (NBIX) Q2 2022 Earnings Call Transcript

NBIX earnings call for the period ending June 30, 2022.

Washington
District-of-columbia
United-states
Japan
Todd-tushla
Anupam-rama-jpmorgan
Kevin-charles-gorman
Raymond-james
Sosei-heptares
Chris-shibutani
Yatin-suneja-guggenheim
Kyle-gano

vimarsana © 2020. All Rights Reserved.